Literature DB >> 16055084

Calmodulin binds to the Rab GTPase activating protein required for insulin-stimulated GLUT4 translocation.

Susan Kane1, Gustav E Lienhard.   

Abstract

Recently, we described a 160 kDa protein with a Rab GTPase activating protein domain that is phosphorylated on multiple sites by the protein kinase Akt (designated AS160). Phosphorylation of AS160 in adipocytes is required for insulin-stimulated translocation of the glucose transporter GLUT4 to the plasma membrane. In the present study, we searched for proteins that interact with the GTPase activating protein (GAP) domain region of AS160 by the yeast two-hybrid screen. This search indicated that calmodulin bound to a small domain just amino terminal to the GAP domain of AS160, and this association has been confirmed by three other methods, including co-immunoprecipitation from lysates of adipocytes. The association was Ca ion dependent. The role of calmodulin binding to AS160 in insulin-stimulated GLUT4 translocation was examined through the generation of a point mutant of AS160 that did not bind calmodulin. This mutation did not interfere with the capacity of AS160 lacking Akt phosphorylation sites to inhibit GLUT4 translocation. Consequently, calmodulin binding is probably not required for the participation of AS160 in insulin-stimulated GLUT4 translocation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16055084     DOI: 10.1016/j.bbrc.2005.07.056

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Substrate specificity and effect on GLUT4 translocation of the Rab GTPase-activating protein Tbc1d1.

Authors:  William G Roach; Jose A Chavez; Cristinel P Mîinea; Gustav E Lienhard
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

2.  Regulation of glucose transporter 4 translocation by the Rab guanosine triphosphatase-activating protein AS160/TBC1D4: role of phosphorylation and membrane association.

Authors:  Jacqueline Stöckli; Jonathan R Davey; Cordula Hohnen-Behrens; Aimin Xu; David E James; Georg Ramm
Journal:  Mol Endocrinol       Date:  2008-09-18

Review 3.  Signaling, cytoskeletal and membrane mechanisms regulating GLUT4 exocytosis.

Authors:  Nolan J Hoffman; Jeffrey S Elmendorf
Journal:  Trends Endocrinol Metab       Date:  2011-01-07       Impact factor: 12.015

4.  AKT and AMP-activated protein kinase regulate TBC1D1 through phosphorylation and its interaction with the cytosolic tail of insulin-regulated aminopeptidase IRAP.

Authors:  Samaneh Mafakheri; Ralf R Flörke; Sibylle Kanngießer; Sonja Hartwig; Lena Espelage; Christian De Wendt; Tina Schönberger; Nele Hamker; Stefan Lehr; Alexandra Chadt; Hadi Al-Hasani
Journal:  J Biol Chem       Date:  2018-10-01       Impact factor: 5.157

5.  Cadmium exposure enhances organic cation transporter 2 trafficking to the kidney membrane and exacerbates cisplatin nephrotoxicity.

Authors:  Hong Yang; Jie Tang; Dong Guo; Qingqing Zhao; Jiagen Wen; Yanjuan Zhang; Obinna N Obianom; Shiwei Zhou; Wei Zhang; Yan Shu
Journal:  Kidney Int       Date:  2019-11-26       Impact factor: 10.612

6.  Cooperative actions of Tbc1d1 and AS160/Tbc1d4 in GLUT4-trafficking activities.

Authors:  Hiroyasu Hatakeyama; Taisuke Morino; Takuya Ishii; Makoto Kanzaki
Journal:  J Biol Chem       Date:  2018-11-27       Impact factor: 5.157

Review 7.  Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic.

Authors:  Kei Sakamoto; Geoffrey D Holman
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-13       Impact factor: 4.310

8.  Regulatory mode shift of Tbc1d1 is required for acquisition of insulin-responsive GLUT4-trafficking activity.

Authors:  Hiroyasu Hatakeyama; Makoto Kanzaki
Journal:  Mol Biol Cell       Date:  2013-01-16       Impact factor: 4.138

9.  Inhibition of contraction-stimulated AMP-activated protein kinase inhibits contraction-stimulated increases in PAS-TBC1D1 and glucose transport without altering PAS-AS160 in rat skeletal muscle.

Authors:  Katsuhiko Funai; Gregory D Cartee
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.